TherapeuticsMD (TXMD) Reports Q1 Loss of $0.24/sh
Tweet
Share
E-mail
Get Alerts TXMD Hot Sheet
Join SI Premium – FREE
TherapeuticsMD (NASDAQ: TXMD) reported Q1 EPS of ($0.24), versus ($2.08) reported last year. Revenue for the quarter came in at $400 thousand, versus $700 thousand reported last year.
For earnings history and earnings-related data on TherapeuticsMD (TXMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- HP shares slide as tech giant forecasts 2027 PC market slump
- Truist Securities Reiterates Buy Rating on DigitalOcean (DOCN)
- LEEF Brands appoints Hirsh Jain to board as independent director
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
